SPIRE HEALTHCARE GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 253 GBX | +0.40% |
|
-0.78% | +11.70% |
| May. 09 | Spire Healthcare touts strong trading, backs outlook | AN |
| May. 09 | Spire Healthcare Reiterates FY24 Guidance | MT |
| Sales 2024 * | 1.54B 1.96B | Sales 2025 * | 1.63B 2.08B | Capitalization | 1.02B 1.3B |
|---|---|---|---|---|---|
| Net income 2024 * | 43M 54.79M | Net income 2025 * | 64M 81.54M | EV / Sales 2024 * | 1.42 x |
| Net Debt 2024 * | 1.16B 1.48B | Net Debt 2025 * | 1.13B 1.44B | EV / Sales 2025 * | 1.32 x |
| P/E ratio 2024 * |
23.7
x | P/E ratio 2025 * |
16
x | Employees | 12,787 |
| Yield 2024 * |
1.18% | Yield 2025 * |
1.55% | Free-Float | 65.3% |
More Fundamentals
* Assessed data
More news
Latest transcript on Spire Healthcare Group plc
More press releases
More news
| 1 day | +0.40% | ||
| 1 week | -0.78% | ||
| 1 month | +2.64% | ||
| 3 months | +12.20% | ||
| 6 months | +13.71% | ||
| Current year | +11.70% |
1 week
248.00
261.00
1 month
245.00270.50
Current year
221.00270.50
1 year
204.00270.50
3 years
201.00270.50
5 years
51.10270.50
10 years
51.10411.00
| Managers | Title | Age | Since |
|---|---|---|---|
Justinian Ash
CEO | Chief Executive Officer | 59 | 17-10-29 |
Harbant Samra
DFI | Director of Finance/CFO | - | 18-09-30 |
Cathy Cale
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ian Cheshire
CHM | Chairman | 64 | 21-03-03 |
Martin Angle
BRD | Director/Board Member | 74 | 19-03-13 |
Natalie Ceeney
BRD | Director/Board Member | 53 | 23-04-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 746 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 253 | +0.40% | 2,381,895 |
| 24-05-30 | 252 | +1.00% | 1,710,008 |
| 24-05-29 | 249.5 | -0.80% | 559,621 |
| 24-05-28 | 251.5 | -1.37% | 405,554 |
| 24-05-24 | 255 | -0.20% | 367,089 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotes
Spire Healthcare Group plc is a United Kingdom-based company that owns and operates private hospitals and clinics in the United Kingdom and provides a range of private healthcare services. The Company offers a range of treatments and services, such as allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, dental surgery, ear, nose and throat, eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, hematology, hand surgery, heart treatments, hip and knee, kidney treatments, men's health, neurosurgery and neurology, pediatrics, physiotherapy, podiatry, skin treatments, spinal surgery and treatments, sports science, urology, vascular surgery, weight loss, and women's health. Its tests and scans include cardiac computerized tomography (CT), CT scans, magnetic resonance imaging (MRI) scans, ultrasound scans, and x-rays.
Calendar
2024-09-11
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.53
GBP
Average target price
3.105
GBP
Spread / Average Target
+22.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.70% | 1.3B | |
| -23.39% | 15.56B | |
| -2.70% | 11.65B | |
| +2.65% | 11.58B | |
| +2.37% | 10.06B | |
| +29.48% | 8.7B | |
| -10.45% | 7.16B | |
| +8.05% | 6.85B | |
| -4.29% | 5.71B | |
| -3.96% | 4.3B |
- Stock Market
- Equities
- SPI Stock
